Management Team

Eric Steen
Founder & CEO

As the CEO of Lygos, Dr. Steen’s primary responsibilities include establishing a strategic vision, managing

Bryce Dille
VP OF FINANCE

Mr. Dille leads Lygos’ finance strategy and oversees the accounting, corporate development, investor relations, tax,

Jason Poulos
CEO Librede

Dr. Poulos is co-founder and CEO of Librede which focuses on the commercialization of sustainable

Nicholas Ohler
VP of Process Development & Manufacturing

Dr. Ohler is responsible for process development and manufacturing activities at Lygos. He supervises the

Andrew Conley
VP of Biology R&D

Dr. Conley leads Lygos' Biology department which performs protein, metabolic and strain engineering using synthetic

Photon Rao
Chief Patent Counsel

Dr. Rao brings 15 years of business-focused IP strategy, procurement and protection experience. He has

Advisors

Jay D. Keasling
Lygos Founder

Dr. Keasling is a Professor of Chemical engineering and Bioengineering at the University of California-Berkeley,

Leonard Katz
Lygos Founder

Dr. Katz currently serves as President of the Society for Industrial Microbiology and Biotechnology and

Richard Bailey
Advisor

Dr. Bailey is currently consulting with numerous industrial biotechnology companies following a successful career spanning

Michael Cockrem
Advisor

Dr. Cockrem has 25+ years experience in process development for commercialization of bio-based chemicals, including

Charles Cooney
Advisor

Dr. Cooney is professor of chemical and biochemical engineering and faculty director for the Deshpande

Jim Millis
Advisor

Mr. Millis is currently Chief Technology Officer of Nature's Fynd and has over 30 years

Stephen del Cardayre
Advisor

Dr. del Cardayre is currently active with several leading synthetic biology and specialty chemical companies.